INO · Inovio Pharmaceuticals, Inc.
$1.10
+0.01 (+0.92%)
At close · Jul 21
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In light of these factors, management believes that there is substantial doubt about the Company's ability to continue as a going concern beyond the late fourth quarter of 2026.”View the 10-Q filed May 13, 2026
Market Cap
$90.50M
Shares
82.27M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-08-13 | — | — | 2026-04-01 | — | 8-K , filed 2026-04-02 |
Key facts
CIK
1055726
CUSIP
45773H409
13F (30d)
10 filings
10 filers
Visit website
Investor relations